Template:Further points for assessing the study: Difference between revisions

Revision as of 11:25, 9 October 2024

This is the "Further points for assessing the study" template.

It should be called in the following format:

{{Further points for assessing the study
|Samples sufficiently large=
|power analysis performed=
|reasons given for samples=
|Ethnicity mentioned=
|Possibility of attention effects=
|Possibility of placebo effects=
|Other reasons=
|Testing for normal distribution=
|Correct application of statistical=
|Correction for multiple testing=
|Measurement of compliance=
|Blinding reliable=
|Check whether blinding was successful=
|Consistent reporting in numbers=
|Sufficient washout period=
|Tested for carry-over=
|Were sequence effects tested=
|Comprehensive and coherent reporting=
|Were side effects systematically recorded=
|Effect sizes reported=
|Side effects taken into account in the interpretation of the results=
|mono- or multicentric=
|Ethics / CoI / Funding=
}}

Edit the page to see the template text.

@@ Line 46: / Line 46: @@
 ! style="text-align:left;" | Measurement of compliance
 | style="text-align:center;" | [[Measurement of compliance::{{{Measurement of compliance|}}}]]
-|-
-! style="text-align:left;" | Blinding reliable
-| style="text-align:center;" | [[Blinding reliable::{{{Blinding reliable|}}}]]
-|-
-! style="text-align:left;" | Check whether blinding (of participants) was successful
-| style="text-align:center;" | [[Check whether blinding was successful::{{{Check whether blinding was successful|}}}]]
 |-
 ! style="text-align:left;" | Consistent reporting in numbers (figures, flowchart, abstract, results)